Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

PATELLAR RETENTION VERSUS PATELLAR RESURFACING DURING TKR – A PROSPECTIVE, RANDOMIZED STUDY



Abstract

Introduction: Existing data in the literature is supporting either patellar retention or patellar resurfacing during primary TKA. There is no clear answer for the question in which cases the patella should be retained or resurfaced during primary TKA.

Materials and Methods: In this prospective study 2 groups of patients with a mean follow up of 34 months after TKA were compared. 83 patients (98 TKA) were implanted with a TKA with patellar retention (group 1) while 93 TKA (86 patients) were done including a patellar resurfacing (group 2). The patients were randomized according to the year of birth. The NexGen® MBK and the LPS were implanted. A dome shaped patellar prosthesis with 3 pegs was used for patellar resurfacing. Clinical Outcomes were based on the knee society score parameters, anterior knee pain, patient satisfaction, feeling of instability, step test while component position and limb alignment were measured by standard radiographs.

Results: No statistical differences between both groups with regard to post-operative anterior knee pain and knee society score were found. We found no pre-operative predictor factors for the development of post-operative anterior knee pain for each group and both together. Patellar maltracking was worse in group 1 than in the resurfaced group (3 cases with patellar subluxation in group 1 versus 2 cases in group 2).

Conclusion: According to the not significant differences for the clinical outcomes between group 1 and 2 we routinely retain the patella. Patellar resurfacing is done only in selective cases.

Correspondence should be addressed to Ms Larissa Welti, Scientific Secretary, EFORT Central Office, Technoparkstrasse 1, CH-8005 Zürich, Switzerland